About Acorai

Acorai is building the world’s first non-invasive cardiac and pulmonary pressure monitoring platform designed to improve how heart failure is managed across inpatient, transitional, and value-based care settings.

Acorai’s platform combines advanced multi-modal sensing with applied machine learning to estimate these pressures non-invasively at the point of care. The goal is to enable better decision-making across diagnosis, therapy optimization, and discharge planning.

Over the past year, Acorai has reached several important milestones:

Completion of the CAPTURE-HF study involving 1,600 patients across 20 hospitals in six countries

Late-breaking clinical data presented at HFSA demonstrating strong prognostic value for rehospitalization risk

FDA Breakthrough Device Designation granted

Pivotal HOSP-HF study launching across the United States, Europe, and Asia

Growing inbound interest from health systems, cardiology leaders, and academic partners

As Acorai prepares for regulatory submission and early commercialization, the company is expanding engagement with experienced healthcare executives who understand care delivery, system economics, and scale.

The Role

This opportunity is designed for senior healthcare executives and operators who understand how new technologies are evaluated, adopted, and scaled within complex healthcare environments.

The engagement is strategic and flexible and focuses on:

Where Acorai creates measurable value for health systems

Adoption dynamics across inpatient, transitional, and value-based care settings

How cardiovascular technologies are operationalized at scale

Strategic positioning ahead of broader commercialization

Time commitment: Approximately 1 to 2 hours per month
Compensation: Equity-based advisory role

Why This Matters

Heart failure is a major driver of several challenges across healthcare systems:

Inpatient utilization and length of stay

CMS penalties and hospital readmissions

Operational variability across discharge decisions

Unmet needs in value-based and population health models

Acorai’s platform is designed to provide earlier and clearer physiological insight at the moments where health systems make their most critical decisions. This supports better outcomes, more efficient care delivery, and scalable adoption.

Why Join Now

Acorai is clinically validated and entering pivotal trials

Advisors will influence how non-invasive hemodynamic monitoring is adopted globally

Early advisors help shape regulatory, clinical, and commercial strategy

Advisory board members receive priority access to Acorai’s current seed extension round alongside institutional and strategic investors

Advisory seats are limited to maintain a highly engaged and focused advisory group

Ideal Profiles

Hospital or health system executives including C-suite leaders, vice presidents, and service-line leaders

Healthcare operators with experience in cardiovascular or acute-care delivery

Leaders in medical devices, diagnostics, or digital health

Executives familiar with regulated healthcare products, reimbursement models, and procurement processes

Compensation and Strategic Alignment

Equity Participation
Advisors receive equity-based compensation in recognition of strategic contributions and long-term alignment with Acorai’s growth.

Seed Round Access
Advisors receive priority access to Acorai’s current seed extension round alongside institutional and strategic healthcare investors.

Equal Opportunity Commitment

Acorai is committed to building a diverse, inclusive, and clinically representative advisory community. The company welcomes applicants from all backgrounds and does not discriminate on the basis of race, gender, ethnicity, disability, age, religion, or any protected characteristic.

Acorai believes diverse clinical and leadership perspectives are essential to transforming heart failure care globally.

‍